[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100583722":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":30,"centralContacts":34,"locations":39,"responsibleParty":55,"collaborators":25,"id":57,"slug":25,"hasResults":58,"nctId":59,"briefTitle":60,"officialTitle":60,"acronym":25,"eligibilityCriteria":61,"healthyVolunteers":58,"sex":62,"minAge":63,"maxAge":64,"enrollmentInfo":65,"targetDuration":25,"studyType":68,"phases":69,"briefSummary":71,"conditions":72,"keywords":75,"overallStatus":42,"whyStopped":25,"lastUpdateSubmitDate":79,"lastUpdatePostDateStruct":80,"startDateStruct":83,"completionDateStruct":85,"leadSponsor":87,"locationsCount":88},{"fullName":5,"class":6},"Konya City Hospital","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Ensure group","EXPERIMENTAL","The first method involves intubating the infant, administering intratracheal surfactant, and then extubating them back to nasal respiratory support (ENSURE method).",[13],"Diagnostic Test: Evaluation of serial lung ultrasound data after ENSURE surfactant treatments",{"label":15,"type":10,"description":16,"interventionNames":17},"Lisa group","The second method involves delivering surfactant via a thin catheter (5F) directly into the trachea while the infant remains on existing nasal respiratory support, without disconnecting them from it (LISA method).",[18],"Diagnostic Test: Evaluation of serial lung ultrasound data after LISA surfactant treatments",[20,26],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":25},"DIAGNOSTIC_TEST","Evaluation of serial lung ultrasound data after ENSURE surfactant treatments","Intubating the infant, administering intratracheal surfactant, and then extubating them back to nasal respiratory support (ENSURE method)",[9],null,{"type":21,"name":27,"description":28,"armGroupLabels":29,"otherNames":25},"Evaluation of serial lung ultrasound data after LISA surfactant treatments","Delivering surfactant via a thin catheter (5F) directly into the trachea while the infant remains on existing nasal respiratory support, without disconnecting them from it (LISA method)",[15],[31],{"name":32,"affiliation":5,"role":33},"MELEK BUYUKEREN","PRINCIPAL_INVESTIGATOR",[35],{"name":32,"role":36,"phone":37,"phoneExt":25,"email":38},"CONTACT","+903323105000","melekbuyukeren@gmail.com",[40],{"facility":41,"status":42,"city":43,"state":44,"zip":45,"country":46,"countryCode":25,"cosmosGeoPoint":47,"geoPoint":52,"contacts":53},"Melek Buyukeren","RECRUITING","Konya","Karatay","42020","Turkey (Türkiye)",{"type":48,"coordinates":49},"Point",[50,51],32.48464,37.87135,{"lat":51,"lon":50},[54],{"name":32,"role":36,"phone":37,"phoneExt":25,"email":38},{"type":33,"investigatorFullName":41,"investigatorTitle":56,"investigatorAffiliation":5,"oldNameTitle":25,"oldOrganization":25},"Associate Professor","100583722",false,"NCT06880016","Evaluation of Serial Lung Ultrasound Data After Surfactant Treatments Applied With Different Methods in Preterm Babies","Inclusion Criteria:\n\n* Infants of families who agree to participate in the study\n* Preterm infants born before 32 weeks of gestation requiring surfactant therapy due to an RDS diagnosis.\n\nExclusion Criteria:\n\n* Infants whose families did not provide consent\n* Infants with a syndromic appearance or congenital heart disease\n* Preterm infants born after 32 weeks of gestation","ALL","1 Day","5 Days",{"count":66,"type":67},68,"ESTIMATED","INTERVENTIONAL",[70],"NA","This study aims to investigate the relationship between the method of surfactant administration and improvements in serial lung ultrasound findings in preterm infants requiring surfactant therapy.",[73,74],"Newborn Complication","Respiratory Distress Syndrome, Newborn",[76,77,78],"NEWBORN","Respiratory Distress Syndrome","surfactant","2026-03-26",{"date":81,"type":82},"2026-03-31","ACTUAL",{"date":84,"type":82},"2024-07-01",{"date":86,"type":67},"2026-10-01",{"name":5,"class":6},1]